FAQs     India     Sitemap

Cancer Treatment

Every year about 85,0000 new Cancer cases are diagnosed in India resulting in about 58,0000 Cancer related death every year. More than 60% of these affected patients are in the prime of their life between the ages of 35 and 65 years. With increasing life expectancy and changing life styles concomitant with development, the number of Cancer cases will be almost three times the current number (National Cancer Programme).

Present standard options of Cancer treatment namely Surgery, Chemotherapy and Radiotherapy result in partial cure with lot of side effects, deterioration of quality of life which further compounds to the emotional and psychological distress associated with Cancer patients. So, how can QMR TherapyTM help Cancer patients?
Treatment & Procedure
Before starting QMR Therapy for Cancer treatment, routine haematological tests and proton density planning film of affected area is done depending on which the QMR dose is calculated by specially designed software. The skin marking is done for focusing the QMR beams. The beams are focused for 1 hr every day, for 28 consecutive days.

Quantum Magnetic Resonance (QMR) is a technology that is made to deliver highly complex quantum electromagnetic pattern in the radio and near radio frequency spectrum, with precise command and control through a machine called a ‘AKTISTM ’. The beams can be precisely controlled and focused onto the cancerous tissues.

By bringing the cell membrane potential from its negativity to its normal potential, the cell reaches a resting state after which it stops dividing, thus causing programmed cell death (Apoptosis) of the tumour tissue and shrinkage of the tumour after a certain period of time.

Based on the trial results and experiences of QMR Therapy, an improved form of the QMR machine called AKTISTM has been developed which will be used for providing palliative care for Cancer patients.

AKTISTM is a computer-controlled device, which generates quantum magnetic resonance beams, by specially designed Magnetic Frequency Generators (MFG) in radio or near sub-radio frequency, which can be focused on the tumour.

Hypothesized Mechanism in Tissue degeneration
It is known that normal resting cell membrane potential (trans membrane potential, TMP) is -70mV to -90mV. It decreases to -40 to -60mV when infected and -15 to -30mV in Cancerous cells. Exposure to QMR beams, 1 hr everyday for 28 consecutive days normalizes the cell membrane potential to its resting state, thereby preventing mitosis of the Cancer cells and initiates apoptosis (programmed cell death).

QMR beams increase the impedance of mitochondrial membrane, thereby cutting down the production of ATP and preventing mitosis. The normal cells are not influenced by the QMR beam exposure as the QMR Magnetic Frequency Generators (MFG) are aimed at the core of the tumour where the beams meet, furthermore, the signals are modulated depending on the proton density of the tumour tissue and impedance of their (normal cells) mitochondrial sensors.

QMR beam exposure also prevents angiogenesis which cuts down the nutrition supply to the tumour tissue.